NEW YORK (GenomeWeb) – NanoString Technologies said on Tuesday that it has signed a deal with investment bank Cowen and Company to sell up to $40 million of its common stock from time to time.

Under the agreement, Cowen may sell the shares through an "at-the-market" offering, in which shares are offered at the prevailing market rates. The firm may also sell the stock by other methods, including through privately negotiated deals.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that gene-edited food may soon be for sale.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.